Valganciclovir Hydrochloride 450mg Tablets
These are oral tablets containing 450mg of valganciclovir hydrochloride, an antiviral medication used to treat cytomegalovirus (CMV) infections in immunocompromised patients. Classified under HTS 3004.90.92.05 as an anti-infective antiviral medicament put up in measured doses for retail sale, consisting of valganciclovir salt in unmixed form.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If imported as bulk active pharmaceutical ingredient
Bulk valganciclovir hydrochloride without measured dosing or retail packaging classified as heterocyclic compounds in Chapter 29.
If medicinal use not established or bulk medicaments
Medicaments not in measured doses for retail sale go to heading 3003 instead of 3004.
If other antiviral formulations not containing specified substances
Antivirals without valganciclovir or peramivir fall under the broader 3004.90.91 category.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Obtain FDA approval and ensure compliance with drug import regulations including NDC labeling
• Provide certificates of analysis confirming valganciclovir hydrochloride content and purity
• Avoid misclassification as unmixed bulk API which falls outside retail dose requirements
Related Products under HTS 3004.90.92.05
Valcyte 450mg Film-Coated Tablets
Brand name Valcyte tablets with 450mg valganciclovir hydrochloride, film-coated for CMV retinitis and prevention in transplant patients. Falls under HTS 3004.90.92.05 due to specific valganciclopivir salt content in measured retail doses as an antiviral anti-infective.
Valganciclovir 50mg/mL Oral Suspension
Liquid oral suspension at 50mg/mL valganciclovir hydrochloride for pediatric or swallowing-impaired patients treating CMV disease. HTS 3004.90.92.05 applies as it's a measured dose antiviral containing valganciclovir salt for retail therapeutic use.
Peramivir 200mg Intravenous Injection
Single-dose 200mg vial of peramivir for IV infusion treating acute influenza in hospitalized patients. Classified in HTS 3004.90.92.05 as antiviral anti-infective in measured sterile doses containing peramivir for therapeutic use.
Rapivab 600mg/60mL IV Solution
Branded Rapivab peramivir injection 600mg in 60mL ready-to-use IV bags for influenza treatment. HTS 3004.90.92.05 due to peramivir content in measured prophylactic/therapeutic doses for retail sale.
Valganciclovir Hydrochloride 900mg Extended-Release Tablets
High-dose 900mg extended-release tablets of valganciclovir HCl for once-daily CMV prophylaxis in transplant recipients. Falls under HTS 3004.90.92.05 as specified antiviral in measured retail doses despite modified release profile.
Pediatric Valganciclovir 250mg Tablets
Smaller 250mg valganciclovir tablets scored for pediatric dosing of CMV infections. HTS 3004.90.92.05 classification as measured antiviral doses containing valganciclovir salt for therapeutic retail sale.